• Products
  • Methods
  • RNAi Effects
  • FAQ
  • Order
  • Terms & Conditions
  • Privacy Policy
  • Company
  • Contact
AteloGene®


Products

AteloGene
in vivo siRNA transfection kit
Product No. Product name Package Price
(excluding tax)
#1392 For local administration
AteloGene® Local Use
1 kit∗ ¥60,000
#1393 For systemic administration
AteloGene® Systemic Use
1 kit∗ ¥60,000
∗For 10 times of administration to mice

Mechanism of siRNA transfection using "AteloGene®" Mechanism



Purpose of use

This product is a kit for delivering siRNA into animal tissue by local or systemic administration in mice and then efficiently introducing it into the cells.




Characteristics




Principle

When mixed with synthetic siRNA at an appropriate concentration and ratio, atelocollagen, which is the major component of "AteloGene®", forms a complex appropriate for administration into the body. siRNA that is prepared into a complex with atelocollagen is efficiently delivered in vivo and introduced into the cells.

Mechanism of siRNA transfection using "AteloGene®" Mechanism




Contents of kit

This kit is intended for 10 times of administration.

- Prefilled syringe (filled with "AteloGene®"): 
Each syringe is for 5 times of administration.
600 µL × 2 syringes
- 10 × siRNA buffer: 3 mL × 1 bottle
- Sterilized water: 3 mL × 1 bottle
- Microtube: 2.0 mL × 2 tubes
- Disposable syringe: 1 mL × 2 syringes
- 18G needle for ejection and suction: 4 needles
- 26G injection needle: 2 needles
- Instruction manual: 1 leaflet



Devices and reagents required other than the kit




Storage

Storage temperature: 2-10℃(do not freeze)
Effective period: 3 years from the manufacturing date indicated on the box
Precautions for storage




Precautions for use

  1. This product is a reagent for research use only. Its application to the human body is strictly prohibited. Do not use it for any purposes other than for research purposes.
  2. Be sure to read the instruction manual before use. The manufacturer is not liable for the results of usage by methods other than that described in the instruction manual. Depending on the type of siRNA, administration target or administration method, the expected effect may not always be obtained.



Industrial property rights

Concerning the technique of introducing the nucleic acid component using this kit and collagen, Dainippon Sumitomo Pharma Co., Ltd. and KOKEN Co., Ltd. has either obtained the patent or the patent is under application (PCT/JP02/06137) in Japan and various countries abroad. The usage of this product is limited to tests and research. Other usage of this product may infringe the patent. Please pay attention in this regard.




For any inquiries, please contact the following.

KOKEN CO., LTD.
1-4-14 Koraku, Bunkyo-ku, Tokyo 112-0004, Japan
Tel : +81-3-3816-3525 Fax : +81-3-3816-3570
Should you need any assistance on web, please contact us via the “Contact” form which
you can reach by clicking the tab on top of any pages.